BACKGROUND. Hypothyroidism is the most common thyroid disease. Mostly, the treatment consists in the thyroid hormone replacement throughout the lifetime of the patient. In this context, therapeutic success depends largely on patient adherence to treatment, and the illness perception is important determinant of behavior that will be issued to the management of the disease. PURPOSE. Understand the illness perception in patients with hypothyroidism and its influence on medication adherence. METHODS. The study has a cross-sectional design and was conducted in the endocrinology clinic of the University Hospital of the Federal University of Sergipe. One hundred and eighty-five patients with a diagnosis of primary hypothyroidism and use of levothyroxine for at least two months were interviewed with regard to socio-demographic and clinical data, perception of hypothyroidism and medication adherence behaviors. To this end, the following instruments were used: socio-demographic and clinical questionnaire, adapted and validated for the Brazilian culture version of Brief Illness Perception Questionnaire and Therapeutic Adherence Scale Morisky. RESULTS. Most patients were female (94.6%) and had lower education (4.9% were illiterate and 48.6% had incomplete primary education) . Their ages ranged from 25 to 79 years, with a mean of 50.8 (SD = 12.1) years. The non-adherence rate obtained was 42.2%, and 34.6% of patients reported unintentional adherence, 4.3% intentional adherence and 3.2% both types of behaviour. It was also found that 26.5% of patients had serum levels of thyroid-stimulating hormone outside the reference range, lying high in 17.3% of patients and 9.2% of them deleted. Furthermore, there was a statistically significant relationship between hormone and medication adherence (p = 0,002). Regarding the illness perception, it was found that patients who reported medication adherence had significantly lower scores in relation to the consequences (p = 0.048), concern (p = 0.046) and emotions (p = 0.019) compared with patients who did not adhere to treatment. CONCLUSION. The high prevalence of non-adherence and the influence of some components of illness perception demonstrated in this study suggest the need for strategies based on knowledge of the illness perceptions of the patient to improve adherence to treatment of hypothyroidism. / INTRODUÇÃO. O hipotireoidismo constitui a doença tireoidiana mais comum. O seu tratamento consiste, na grande maioria dos casos, na reposição do hormônio tireoidiano ao longo de toda a vida do paciente. Nesse contexto, o sucesso terapêutico depende em grande parte da adesão do paciente ao tratamento proposto, sendo que a percepção da doença é importante determinante dos comportamentos que serão emitidos para o gerenciamento da enfermidade. OBJETIVO. Compreender a percepção da doença em pacientes com hipotireoidismo e a sua influência sobre a adesão ao tratamento. METODOLOGIA. O estudo possui delineamento transversal e foi realizado no ambulatório de endocrinologia do Hospital Universitário da Universidade Federal de Sergipe. Foram entrevistados 185 pacientes com diagnóstico prévio de hipotireoidismo primário e em uso de levotiroxina há pelo menos dois meses em relação aos dados sócio-demográficos e clínicos, percepção acerca do hipotireoidismo e comportamentos de adesão ao tratamento. Para tanto, os seguintes instrumentos foram utilizados: questionário sócio-demográfico e clínico, versão adaptada e validada para a cultura brasileira do Brief Illness Perception Questionnaire e Escala de Adesão Terapêutica de Morisky. RESULTADOS. A maioria dos pacientes era do sexo feminino (94,6%) e possuía baixa escolaridade (4,9% eram analfabetos e 48,6% tinham o ensino fundamental incompleto). A faixa etária variou de 25 a 79 anos, com média de 50,8 (DP = 12,1) anos. A taxa de não adesão obtida foi de 42,2%, sendo que 34,6% dos pacientes relataram não adesão não intencional, 4,3% não adesão intencional e 3,2% não adesão mista. Também foi verificado que 26,5% dos pacientes possuíam níveis séricos do hormônio tireoestimulante fora da faixa de referência, encontrando-se elevados em 17,3% dos pacientes e suprimidos em 9,2% deles. Ademais, houve relação estatisticamente significativa entre o hormônio e adesão ao tratamento (p = 0,002). Quanto à percepção da doença, verificou-se que os pacientes que relataram aderir ao tratamento apresentaram escores significativamente mais baixos em relação às dimensões consequências (p = 0,048), preocupação (p = 0,046) e emoções (p = 0,019) em comparação com os pacientes que não aderiram ao tratamento. CONCLUSÃO. A alta prevalência de não adesão ao tratamento e a influência de alguns componentes da percepção da doença demonstradas neste estudo evidenciam a necessidade de estratégias com base no conhecimento das percepções de doença do paciente para favorecer a adesão ao tratamento do hipotireoidismo.

Submitted by Cássia Santos (cassia.bcufg@gmail.com) on 2015-10-26T10:38:27Z No. of bitstreams: 2 Tese - Adriana do Prado Barbosa - 2015.pdf: 900945 bytes, checksum: c7a5ed7dcaeb54e2967829169a9de269 (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5) / Approved for entry into archive by Luciana Ferreira (lucgeral@gmail.com) on 2015-10-26T13:18:13Z (GMT) No. of bitstreams: 2 Tese - Adriana do Prado Barbosa - 2015.pdf: 900945 bytes, checksum: c7a5ed7dcaeb54e2967829169a9de269 (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5) / Made available in DSpace on 2015-10-26T13:18:13Z (GMT). No. of bitstreams: 2 Tese - Adriana do Prado Barbosa - 2015.pdf: 900945 bytes, checksum: c7a5ed7dcaeb54e2967829169a9de269 (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5) Previous issue date: 2015-04-10 / Fundação de Amparo à Pesquisa do Estado de Goiás - FAPEG / The treatment of chronic myeloid leukemia (CML) has changed dramatically with the advent of imatinib mesylate (IM). Besides the convenience of oral use, other benefits were achieved with the new drug, with faster therapeutic responses and increased survival, giving the CML similar characteristics as chronic diseases. In this scenario, there was another challenge, drug compliance, since a significant proportion of patients fail to ingest all the prescribed doses of imatinib. The concern was to optimize the adherence of CML patients, the hematology ambulatory at the Clinical Hospital of the Federal University of Goias (HC-UFG), led the authoress to create a film cartoon, as a pro-adhesion educational intervention model. To investigate the effectiveness of this new educational material, we used in 65 patients three adherence measures, two indirect (Morisky Test and Molecular Response [MR]) and direct (plasma dosage of IM), before and after the screening of film. In univariate analysis, from the Morisky Test, the film was striking, with increased adherent patients, which increased from 15 (23.1%) to 43 (66.1%). The results of MR showed an improvement trend after the movie, because the positive molecular response (major MR or complete MR) increased from 81.5% to 86.1%. Regarding the serum levels of IM, with daily doses of 400-800 mg IM, the premovie samples showed higher average than the post-movie (2473.16 ± 1049.55 ng/ml versus 1414.72 ± 715 73 ng/ml), with a variation coefficients interpatients of 43.4% and 50.6%, respectively. This high dispersion index found has been reported by other authors. By multivariate analysis, patients were divided into three groups. The first brought together compliant patients before and after the film with a good therapeutic response (major MR) after the intervention. It was: patients over 53 years old, females, with associated diseases before and after the treatment of CML that use more than two drugs in addition to imatinib. The second group was marked by the change of not adherence pre to adherence post-film. Its features were younger than or equal to 53, the absence of other disease before the CML, the use of less than two drugs and complete molecular response after the film. In the third group, we observed patients without molecular response before and after the educational intervention and no medication adherence after the film. They had in common their age (less than or equal to 53 years), and drug discontinuation due to adverse reactions. The last represents the set of patients resistant to the educational film, drawing attention to the fact that only one pro-adhesion method may be insufficient for all individuals. It is concluded that medication adherence was higher among patients older than 53 years, the educational film is an effective proadhesion assistance and continuing education, if combined with another method, it could help maintain or enhance the benefits achieved in this work. / O tratamento da leucemia mielóide crônica (LMC) mudou radicalmente com o advento do mesilato de imatinibe (MI). Além da comodidade do uso oral, outros benefícios foram alcançados com o novo fármaco, como respostas terapêuticas mais rápidas e aumento da sobrevida, dando `a LMC características semelhantes `as de doenças crônicas. Neste cenário, surgiu outro desafio, a adesão medicamentosa, pois uma proporção significativa de pacientes deixa de ingerir a dose prescrita de imatinibe. A preocupação em otimizar a adesão dos pacientes com LMC, do Ambulatório de Hematologia do Hospital das Clínicas da Universidade Federal de Goiás (HC-UFG), motivou a autora a criar um filme em desenho animado, como modelo de intervenção educativa pró-adesão. Para investigar a eficácia deste novo material educativo, empregou-se, em 65 pacientes, três medidas de adesão, duas indiretas (Teste de Morisky e Resposta Molecular [RM]) e uma direta (dosagem plasmática do MI), antes e depois da exibição do filme. Em análise univariada, pelo teste de Morisky, o filme foi impactante, com aumento dos pacientes aderentes, que passaram de 15 (23,1%) para 43 (66,1%). Os resultados da RM indicaram uma tendência de melhora após o filme, pois a resposta molecular positiva (RM maior ou RM completa) passou de 81,5% para 86,1%. Em relação `a dosagem sérica do MI, com doses diárias entre 400-800 mg de MI, as amostras pré-filme apresentaram média superior `as do pósfilme (2.473,16 ± 1.049,55 ng/ml versus 1.414,72 ± 715,73 ng/ml), com coeficientes de variação interpaciente de 43,4% e 50,6%, respectivamente. Este elevado índice de dispersão encontrado tem sido relatado por outros autores. Pela análise multivariada, os pacientes foram separados em três grupos. O primeiro, reuniu os pacientes aderentes antes e após o filme e com boa resposta terapêutica (RM maior) após a intervenção. Foram eles: os doentes com mais de 53 anos, do gênero feminino, com doenças associadas antes e após o tratamento da LMC e que usam mais de dois medicamentos além do imatinibe. O segundo grupo foi marcado pela mudança de não adesão pré para adesão pós-filme. Suas características foram idade menor ou igual a 53, ausência de outra doença antes da LMC, uso de menos de dois medicamentos e resposta molecular completa pós-filme. No terceiro grupo, observou-se pacientes sem resposta molecular antes e depois da intervenção educativa, bem como não adesão medicamentosa após o filme. Eles tinham em comum a idade, menor ou igual a 53 anos, e suspensão do medicamento por reação adversa. Estes últimos representam o conjunto de pacientes resistentes ao filme educacional, chamando atenção para o fato de que somente um método pró-adesão pode ser insuficiente para todos os indivíduos. Conclui-se que a adesão medicamentosa foi maior entre os pacientes maiores de 53 anos, que o filme educativo é uma intervenção pró-adesão eficaz e que a educação continuada, aliada a outro método, poderia ajudar a manter ou ampliar os benefícios conquistados neste trabalho.

INTRODUÇÃO: O sucesso da terapia antirretroviral de alta potência depende da manutenção de altas taxas de adesão do paciente ao tratamento, o que provocou a implementação de intervenções para melhorar a adesão nos programas de Aids em todo o mundo. No Brasil há poucos estudos sobre a efetividade destas intervenções e apenas um foi aleatório e controlado. Este estudo objetiva avaliar a efetividade de uma intervenção psicossocial para melhorar a adesão de pessoas vivendo com HIV e Aids à terapia antirretroviral. MÉTODOS: Consentiram em participar do estudo 121 dos 363 pacientes com carga viral >50 cópias/ml e com mesmo esquema antirretroviral por no mínimo seis meses, em acompanhamento no Centro de Referência e Treinamento em DST e Aids - São Paulo/Brasil. Todos os participantes utilizaram monitoramento eletrônico de medicação por 60 dias sendo então aleatorizados na proporção de 1:1 para os grupos de intervenção (GI) e controle (GC). O GI recebeu o cuidado usual do serviço e participou de quatro encontros individuais de uma hora com profissional de saúde previamente capacitado a intervalos de 15 dias. O GC recebeu apenas o cuidado usual. O desfecho primário foi a adesão medida pelo monitoramento eletrônico no momento da alocação nos grupos (início da intervenção), após 30, 60, 90 e 120 dias. A medida secundária foi a carga viral no início e no final do estudo. A análise foi feita por intenção de tratamento. RESULTADOS: Não houve diferença estatística significativa nas medidas de adesão segundo percentual de doses tomadas, de doses tomadas no horário e proporção de pacientes com adesão >= 95%, entre os grupos GI e GC durante o período da intervenção (medidas de 30 e 60 dias). Entretanto, a evolução da proporção de pacientes com adesão >= 95% entre o início da intervenção e o primeiro seguimento pós intervenção (medida de 90 dias) mostrou aumento no GI e declínio no GC, embora sem significado estatístico. O GI mostrou queda significativa em todas as medidas de adesão de 60 dias (final da intervenção) e 120 dias (final do seguimento). A carga viral média diminuiu significativamente entre o início e o final do estudo em ambos os grupos, sem diferença estatística significativa entre o GI e o GC. CONCLUSÕES: A intervenção não provocou aumento na adesão dos participantes do estudo. O discreto aumento na proporção de aderentes no grupo da intervenção em relação ao controle durante o período da intervenção sugere, contudo, que o número de participantes - bem menor do que a estimativa amostral - possa ter comprometido os resultados pela falta de poder estatístico suficiente para mostrar diferenças entre os grupos. A redução nos níveis de carga viral foi benéfica, pois se associa com a diminuição da mortalidade e da progressão para Aids. Registro do Ensaio: National Institute of Healthy - Clinical Trials: NCTOO716040 / INTRODUCTION: The success of the antiretroviral therapy depends on high patient adherence to treatment, which has led to the implementation of interventions aimed at enhancing adherence in AIDS programs worldwide. Few studies have been performed in Brazil investigating the effectiveness of these interventions, and only one randomized controlled study is available. The aim of this study is to assess the effectiveness of a psychosocial intervention in improving adherence to antiretroviral treatment among individuals living with HIV and AIDS. METHOD: A total of 121 out of 363 patients with viral load > 50 copies/ml and in use of the same antiretroviral scheme for at least six months were recruited from the Reference and Training Center for STD and AIDS - São Paulo/Brazil. All participants used electronic monitoring of medication for 60 days and were randomized in a 1:1 ratio for the intervention group (IG) and control (CG) The IG, in addition to receiving standard care, took part in four 1-hour meetings, held every fortnight by a trained-health professional. The CG received standard care only. The study was run for six month. The primary outcome was adherence measured by electronic monitoring at the time of allocation groups (commencement of intervention), after 30, 60, 90 and 120 days. The secondary measure was the viral load at baseline and end-point of the study. The analysis was done by intention to treat. RESULTS: Comparison between IG and CG during the intervention period revealed no statistically significant difference in adherence in terms of percentage of doses taken, percentage of doses taken on time, or proportion of patients with adherence >= 95%. However, the evolution of the proportion of patients with adherence >= 95% between the commencement of intervention and follow-up after first intervention (as of 90 days) showed increased adherence in the GI and a tendency for reduced adherence in the CG, although this did not reach statistical significance. A significant decrease in all measures of adherence was observed between 60 days (end of intervention) and 120 days (study end-point). Viral load was found to decrease between baseline and study end-point in both groups (p<0.0001), but presented no statistically significant difference between the IG and CG. CONCLUSIONS: The intervention did not lead to increased adherence among study participants The slight increase in the proportion of adherent participants in the intervention group compared to control during the intervention period suggests, however, that the number of participants - far less than the estimated sample-may have affected the results by the lack of sufficient statistical power to show differences between the groups. Reduced viral load can be beneficial to patients since it is associated with lower mortality and disease progression. National Institute of Healthy - Clinical Trials: NCTOO716040

A adesão do paciente ao tratamento é crucial para a efetividade dos programas de aids. O Programa Brasileiro recomenda monitorar a adesão e incorporar ao cuidado atividades de promoção, tais como atendimentos individuais com foco em adesão. Revisões sistemáticas apontam maior efetividade das intervenções complexas, que incluem sessões de conversas entre profissional-paciente: informativas, educativas e aconselhamentos motivacionais. Criticam: insuficiente explicitação das bases teóricometodológicas das intervenções; enfoque excessivo no nível individual com baixa incorporação do contexto sociocultural; insuficiência de informação acerca da fidelidade aos protocolos. Poucos estudos descrevem a \"intimidade\" das sessões. Planejada para o cuidado individual, uma modalidade de intervenção psicossocial de apoio à adesão teve seu protocolo implementado em ensaio clínico com pacientes adultos, com carga viral detectável, em serviço especializado do SUS, em São Paulo- Brasil. Suas bases teórico-metodológicas: Quadro da Vulnerabilidade e Direitos Humanos na dimensão psicossocial do Cuidado, filiados a uma perspectiva construcionista de psicologia social na saúde. Focada na noção de sucesso prático, a intervenção objetivou contribuir para que as pessoas construíssem formas de conviver melhor com o tratamento que lhes fossem mais convenientes. Baseada na interação profissional-paciente buscou intensificar a dialogia mediante a exploração dos sentidos intersubjetivos que as \"tomadas\" das medicações adquirem em diferentes cenas/cenários. Para avaliar qualitativamente a implementação selecionaram-se 12 casos (4 de cada uma das profissionais que conduziram a intervenção) entre os 44 pacientes do grupo experimental. A análise contemplou dois eixos interdependentes: a) fidelidade da implementação ao protocolo; b) qualidade dialógica das conversações. Apresentamse os resultados em três artigos. A variação nas modalidades e enfoques comunicacionais implementados permitiu a classificação em quatro níveis crescentes de fidelidade ao protocolo: nível 1 (3 casos), nível 2 (6), nível 3 (1), nível 4 (2). A inflexão na direção da dialogia não ocorreu plenamente. Princípios relacionais como solidariedade, não repreensão, foram bem desenvolvidos. As conversas valorizaram experiências singulares de dificuldades com o tratamento e produziram coentendimentos sobre o que acontecia cotidianamente. Entretanto, a decodificação de sentidos na compreensão \"dos problemas\" e criação de \"soluções\" priorizou o nível individual cognitivo-comportamental. Por exemplo, ao invés de dialogar sobre atrasos/perdas de doses em situações sociais relacionadas ao estigma/discriminação, o sentido \"problemas de memória\" prevaleceu na decodificação das falhas no tratamento. Foi incipiente a incorporação de dimensões socioculturais e programáticas ao entendimento das situações e construção/imaginação de estratégias para lidar com \"impasses\" que implicavam prejuízos à adesão. Mesclados à comunicação de enfoque cognitivo-comportamental ocorreram momentos dialógicos que se mostraram mais promissores à construção pelos participantes de enunciados de satisfação, bem-estar, intenções e mudanças práticas benéficas à adesão. Situações psicossociais dos pacientes influíram sobre a comunicação. Quanto mais complexas, desafiam \"o como dialogar\" sobre aspectos graves, sinérgicos e multidimensionais que prejudicam a saúde. São necessárias, mas insuficientes, estratégias que aprimorem a qualidade comunicacional e o enfoque psicossocial das intervenções em adesão nos serviços. Devem complementálas: a coordenação do Cuidado em equipe e ações clínicas e sociais, imediatas e objetivas, para mitigar situações que implicam graves vulnerabilidades, prejudiciais tanto à adesão ao tratamento da aids como à saúde integral / Patient\'s adherence to treatment is essential to the effectiveness of AIDS programs. The Brazilian Program recommends monitoring adherence and incorporating activities to care that promote adherence, such as individual care focusing adherence. Systematic reviews point towards greater effectiveness of complex interventions, which include conversation sessions - educational, informative, motivational counseling - between the health professional and the patient. They criticize: incomplete explanation of the theoretical-methodological bases of interventions; excessive focus on the individual level, with low incorporation of the sociocultural context; insufficient information on the fidelity to protocols. Few studies describe the \"intimacy\" of the conversation sessions. Planned for the individual care, a modality of psychosocial intervention supporting adherence had its protocol implemented in a clinical trial with adult patients with detectable viral load in a specialized care service of the Brazilian Unified Health System (SUS), in São Paulo. The following theoretical-methodological bases were adopted: the Framework of Vulnerability and Human Rights in the psychosocial dimension of Care, affiliated to a social psychology constructionist perspective in health. Focused on the notion of practical success, the intervention aimed at contributing so that people would build ways of coping better with the treatment which was the most convenient for them. Based on the health professional-patient interaction, it sought to intensify dialogic in exploring intersubjective meanings that the medication intake acquires in different scenes/scenarios. In order to qualitatively evaluate implementation, 12 cases (4 cases of each one of the health professionals who conducted the intervention) were selected among 44 cases of the experimental group. The analysis comprised two interdependent axes: a) implementation fidelity to protocol; and b) dialogic quality of conversations. The findings are presented in three papers. Variation in the implemented modalities and communicational approaches allowed the classification in four levels of increasing fidelity to protocol: level 1 (3 cases), level 2 (6 cases), level 3 (1 case), and level 4 (2 cases). Inflection towards dialogic has not completely occurred. Relational principles, such as solidarity and no reprimand, were well developed. The conversations valued singular experiences of difficulties with the treatment. Furthermore, they produced co-understandings on what happened in the daily routine. Nevertheless, the decoding of meanings in understanding \"problems\" and creating \"solutions\" prioritized the cognitive-behavioral individual level. For example, rather than dialoguing on delays/abolishing doses of medication intake in social situations concerning stigma/discrimination, it prevailed the sense of \"memory problems\" in decoding treatment failures. Programmatic and sociocultural dimensions were incipiently incorporated to the understanding of contexts and construction/imagination of strategies to cope with \"impasses\" which implied adherence losses. Mingled with the communication of cognitive-behavioral approach, there were more dialogic moments which showed to be more promising to the construction by the participants of utterances regarding satisfaction, well-being, intentions, and beneficial and practical changes to adherence. The psychosocial situations of patients influenced communication. The more complex, the more they challenge \"how to have a conversation\" about multidimensional, synergistic, serious issues which harm health. It is necessary, but insufficient, to have strategies which enhance the communication quality and psychosocial approach of adherence interventions in care. The coordination of Care as a team and social and clinical actions, both immediate and objective, should complement them in order to mitigate situations which imply serious vulnerabilities that impair AIDS treatment adherence as well as the overall health

Submitted by Fabiana Gonçalves Pinto (benf@ndc.uff.br) on 2015-10-16T13:04:09Z No. of bitstreams: 1 Ana Maria Ferraz Barros.pdf: 1597352 bytes, checksum: 97df8fbfb2f10f7fd335cad0146ae9c8 (MD5) / Made available in DSpace on 2015-10-16T13:04:09Z (GMT). No. of bitstreams: 1 Ana Maria Ferraz Barros.pdf: 1597352 bytes, checksum: 97df8fbfb2f10f7fd335cad0146ae9c8 (MD5) Previous issue date: 2014 / Mestrado Profissional em Enfermagem Assistencial / Esse estudo se propõe a demonstrar, no universo de participantes do Grupo SOL, certo modo de operar o acolhimento grupal, como uma tecnologia, que agregada ao tratamento da PVHA, influencia na construção da adesão ao tratamento. Trata-se de uma pesquisa qualitativa, de natureza híbrida, exploratória e descritiva, que utilizará como técnica a análise documental e a entrevista semiestruturada dos participantes do grupo em questão, para a produção dos dados. Num primeiro momento, a intenção é dar visibilidade à história do grupo e caracterizar a sua composição e suas dinâmicas, para, a partir daí, buscar-se apreender os seus possíveis efeitos junto aos participantes e analisar se, e em que sentido, tais dinâmicas puderam contribuir para a adesão ao tratamento proposto pela equipe de saúde e para a integração social, diante da necessidade de construir outra e nova forma de ver e viver a vida, uma vez se sabendo pessoa vivendo com HIV/AIDS (PVHA). Como resultado, espera-se dar expressão à produção dos sentidos de saúde, construídos no Grupo SOL, e avaliar se essa modalidade de operar um grupo pode ser considerada como uma tecnologia facilitadora do acolhimento para esses tipos de usuários, em sua “nova perspectiva de vida”, e efetivamente contribuir com a produção do cuidado para indivíduos em tratamento de HIV/AIDS. Além disso, também se espera colaborar no sentido de demonstrar aqueles que se propõem a cuidar de PVHA, como pode ser adequado para a reterritorialização existencial desses indivíduos, por um lado, o compartilhar horizontalizado das angústias que advém dessa condição e, por outro, a socialização democrática das questões que se inscrevem e interferem nos modos de ser e de viver desses indivíduos que vivem com HIV/AIDS. / This study aims to demonstrate, in the universe of SOL Group participants, a way to operate the group hosting, as a technology, which, aggregated with the PLHA treatment, influences the construction of treatment adherence. It is a qualitative research with hybrid, exploratory and descriptive nature, that will use as technique the documentary analysis and semi-structured interviews with this referred group participants, in order to produce all data. In a first moment, the intention is to give visibility to the group history characterizing its composition and dynamics, and then seek to apprehend their possible effects among the participants and examine whether, and in what sense, these dynamics could contribute with the treatment adherence proposed by the professional health team and to social integration, faced with the necessity to build another new way of seeing and living life, considering the fact that they are individuals who are living with HIV/AIDS (PLHA). As a result, it is expected to give expression to the health production meanings, constructed within the SOL Group, and assess whether this form to operate a group can be considered as an enabling hosting technology for these kinds of users, in their "new perspective of life", and effectively contribute to the production of care for individuals in treatment of HIV/AIDS. In addition, it also hopes to collaborate in order to clarify those who propose to take care of PLHA, as it may be appropriate for the existential reterritorialization of these individuals, on the one hand, the share of horizontal anguish that comes from that condition and, on the other hand, the democratic socialization of issues that appear and interfere with the ways of being and living of those individuals with HIV/AIDS.

No description available.

Medication adherence in patients with asthma and chronic obstructive pulmonary disease (COPD) is notoriously low and is associated with suboptimal therapeutic outcomes. To intervene effectively, family physicians need to assess medication adherence efficiently and accurately. Otherwise, failure to detect nonadherence may further reduce patient disease control and result in unnecessary treatment escalation that can increase the risk of adverse events and lead to more complex and costly drug regimens. The overarching goal of this thesis was to investigate how the use of secondary healthcare data can be leveraged to optimize medication adherence in clinical practice. Methodological considerations to facilitate our understanding of treatment escalation in asthma using secondary healthcare data were also examined. In the first part of my doctoral research program, I led a project which aimed at developing e-MEDRESP, a novel web-based tool built from pharmacy claims data that provides to family physicians with objective and easily interpretable information on patient adherence to asthma/COPD medications. This tool was developed in collaboration with family physicians and patients using a framework inspired by user-centered design principles. As part of a feasibility study, e-MEDRESP was subsequently implemented in electronic medical records across several family medicine clinics in Quebec (346 patients, 19 physicians). Findings showed that its integration within physician workflow was feasible. Physicians reported that the tool helped to: 1) better evaluate their patients’ medication adherence; and 2) adjust prescribed therapies, with mean ± sd ratings (5-point Likert scale) of 4.8±0.7 and 4.3±0.9, respectively. A pre-post analysis did not reveal improvement in adherence among patients whose physician consulted e-MEDRESP during a medical visit. However, significant improvements in adherence for inhaled corticosteroids (Proportion of days covered (PDC): 26.4% (95% CI: 14.3-39.3%)) and long-acting muscarinic agents (PDC: 26.4% (95% CI: 12.4-40.2%)) were observed among patients whose adherence level was less than 80% in the 6-month period prior to the medical visit. The second part of this research program consisted of two studies which laid the groundwork to estimate the association between medication adherence and treatment escalation in asthma using Canadian healthcare administrative data, a phenomenon that is currently under-explored in the literature. Prior to embarking in this study, it is important to ensure that healthcare administrative databases can be used to identify asthma patients and treatment escalations in an adequate manner. First, a systematic review was conducted to obtain an overview of the available evidence supporting the validity of algorithms to identify asthma patients in healthcare administrative databases. The algorithm developed by Gershon et al. (Canadian Respiratory Journal, 2009;16(6):183-188) comprising ≥2 ambulatory medical visits or ≥1 hospitalization for asthma over two years had the best trade-off between sensitivity (84 %) and specificity (77%). Second, an operational definition of treatment escalation was developed through a Delphi study that incorporated an expert consensus process. This definition includes 7 steps and was inspired by the 2020 Global for Initiative for Asthma treatment guidelines. I plan to integrate the definitions obtained from these two studies in a future cohort study which aims to examine the association between medication adherence and treatment escalation in asthma. My research provides compelling evidence on the importance of developing and evaluating the feasibility of implementing tools which can aid physicians in assessing medication adherence in clinical practice and extends the literature on treatment escalation in asthma. / L’adhésion aux médicaments chez les patients présentant un asthme ou une maladie pulmonaire obstructive chronique (MPOC) est reconnue pour être faible. Pour intervenir efficacement, les médecins de famille doivent évaluer de manière précise l’adhésion aux médicaments. Ne pas détecter la non-adhésion peut réduire davantage la maîtrise de la maladie, entraîner une intensification non-nécessaire du traitement, mener à des schémas pharmacologiques plus complexes et coûteux et par conséquent, augmenter le risque d’événements indésirables. La présente thèse vise à approfondir les connaissances sur l'usage secondaire des données médico-administratives afin d’optimiser l’adhésion et l’usage des médicaments chez les patients atteints de maladies respiratoires chronique, au moyen d’une approche méthodologique mixte de recherche. Plusieurs questions méthodologiques cruciales concernant l’étude de l’intensification du traitement en asthme ont également été abordées. Le premier axe porte sur le développement de l’outil e-MEDRESP, qui s’appuie sur les renouvellements d’ordonnances et qui est conçu pour donner rapidement accès aux médecins de famille à une mesure objective et facilement interprétable de l’adhésion aux médicaments utilisés dans le traitement de l’asthme et de la MPOC. L’outil a été développé en collaboration avec des médecins de famille et des patients à l’aide de groupes de discussion et d’entrevues individuelles. Dans le cadre d’une étude de faisabilité, l’outil e-MEDRESP a été par la suite implanté dans les dossiers médicaux électroniques de plusieurs cliniques de médecine familiale au Québec (346 patients, 19 médecins). Les résultats ont montré que l’intégration de d’e-MEDRESP dans le flux de travail des médecins était faisable. Les médecins ont indiqué que l’outil leur a permis de : 1) mieux évaluer l’adhésion aux médicaments de leurs patients (cote moyenne et écart-type sur une échelle de Likert à 5 points [perception d’accord] de 4,8±0,7); et 2) ajuster les traitements prescrits (4,8±0,7 et 4.3±0,9). Une analyse pré-post n’a pas révélé d’amélioration au niveau de l’adhésion aux médicaments chez les patients dont le médecin a consulté e-MEDRESP lors d’une visite médicale. Toutefois, une amélioration statistiquement significative a été observée chez les patients dont le niveau d’adhésion était inférieur à 80 % au cours de la période de six mois précédant la visite et qui étaient traités par des corticostéroïdes inhalés (Proportion of days covered (PDC) = 26,4 % (IC à 95 % : 14,3-39,3 %) ou des antagonistes muscariniques à action prolongée (PDC = 26,9 % (IC à 95 % : 12,4-40,2 %)). Le deuxième axe présente des travaux préparatoires à la conduite d’une cohorte qui sera réalisée à partir de bases de données médico-administratives et qui aura comme objectif d’estimer l’association entre l’adhésion aux médicaments et l’intensification du traitement de l’asthme, une question peu explorée à ce jour. Avant de débuter une telle étude, il est important de s’assurer que les bases de données médico-administratives peuvent être utilisées pour identifier de manière adéquate les patients asthmatiques et l’intensification du traitement. Dans un premier temps, une revue systématique a été effectuée pour identifier les données probantes disponibles concernant la validité des algorithmes permettant d’identifier les patients asthmatiques dans les bases de données médico-administratives. L’algorithme qui a été développé par Gershon et coll. (Revue canadienne de pneumologie, 2009; vol. 16, no 6, p. 183-188), qui comprenait deux visites médicales ambulatoires ou une hospitalisation pour asthme sur deux ans, présentait le meilleur compromis entre la sensibilité (84 %) et la spécificité (77 %). Dans un second temps, une définition opérationnelle de l’intensification du traitement a été élaborée dans le cadre d’une étude Delphi qui incorporait un processus consensuel d’experts. Cette définition comprend sept étapes et s’inspire des lignes directrices 2020 de l'initiative mondiale de lutte contre l'asthme. Les définitions obtenues à partir de ces deux études seront intégrées dans l’étude de cohorte. Les études constituant cette thèse démontrent l’importance de développer des outils qui permettent aux médecins d’évaluer l’adhésion aux médicaments dans leur pratique clinique, en plus d’enrichir la littérature scientifique médicale sur l’intensification du traitement chez les patients asthmatiques.

Indiana University-Purdue University Indianapolis (IUPUI) / Medication adherence remains a problem among Type-2 diabetes (T2D) patients despite availability of effective treatments. Three analyses of extant data sets were conducted to examine barriers to using medication as prescribed as an alternate method to assess medication adherence: 1) development and psychometric evaluation of the Murage-Marrero-Monahan-Medication barriers (4M) scale to assess patients’ perceived barriers; 2) patient demographic factors associated with barriers to using medication as prescribed, and 3) the association between patients’ perceived barriers to medication use and cardiovascular disease (CVD) risk factor control.Twelve focus groups and a cross-sectional study of 362 T2D patients contributed to develop and evaluate psychometric properties of the 4M scale. A cross-sectional survey of 964 T2D patients was used for the other two studies. Analysis of covariance identified demographic factors associated with reported barriers. Multivariable logistic regression was used to identify barriers associated with CVD risk factors (glucose, blood pressure and lipids) categorized as either poor or good control. Exploratory factor analysis with Varimax rotation resulted in a 19-item 4M scale with acceptable psychometric properties. As a five-domain (or single-domain) structure, coefficient alpha ranged from 0.70 to 0.83 (0.92). Both structures demonstrated discriminant validity and known-group validity. Age was inversely associated with all identified barriers while income was inversely associated with poor communication with providers and side effects. A unit increase in the overall barrier mean score on the 4M scale was associated with 92% increase in the odds of having poor control of two or more CVD risk factors compared to good control of all three risk factors (adjusted OR=1.92, 95% CI: 1.16–3.17; p<0.05). The 4M scale demonstrated acceptable psychometric properties in assessing barriers to using medication among T2D patients. Poor medication adherence has been previously associated with CVD risk. In this study, greater barriers were associated with poorer control of CVD risk factors making barriers a potential alternative to medication adherence, whose current assessment methods are limited. The 4M scale has the advantage to identify specific barriers inhibiting medication use that can facilitate patient-provider discussions and the development of targeted interventions. / Some parts of this dissertation work were jointly funded by Program Announcement 04005 from the Centers for Disease Control and Prevention (Division of Diabetes Translation) and the National Institute of Diabetes and Digestive and Kidney Diseases. The findings and conclusions in this report are those of the author(s) and do not necessarily represent the views of the funding agency(s).

No description available.

The lack of medication adherence leads to an incremental risk of diseases which can be a major burden on the individual, healthcare system, and society. Hence, healthcare professionals have a central role and should manage, guide, educate, and make their patient more involved in their treatment and thereby promoting a better medication adherence. Medication adherence is a great challenge for many patients with chronic conditions, elderly patient, or patient prescribed to long-term medication. The rapid development and deployment of mobile phones in the healthcare industry has an important role to play in this area and has led to the development of new phone features and applications that can help both caregivers and patients with managing and monitoring medication intakes. This development and support of mobile phones and applications have created and improved doctor-patient interaction. Today, there is no easy way for healthcare professionals to monitor and help patients with their medication intakes. A solution to this problem is to develop a mobile application that communicates with a smart pillbox via near field communication (NFC) to monitor, manage, and improve patient’s medication intakes in an easy and accessible manner. Using NFC as a communication technology allows data to be wirelessly transferred from phone to pillbox and vice versa. This solution will help healthcare professionals to create better treatment conditions and fewer side effects for their patients. These patients will be more knowledgeable and motivated to take greater responsibility in following doctor’s instructions, thereby improving their treatment process. The application is tested and evaluated during every iteration phase of the development process. These tests have been conducted by allowing healthcare professionals to test the application and provide feedback on their experience when using the app. Conducting these tests have helped with generating new ideas, features, and functionalities, but also helped to improve the user interface to make the application as user-friendly as possible. / Bristen på medicinering följsamhet leder till en ökad risk för sjukdomar som kan vara en stor belastning för individen, vårdsystemet och samhället. Hälsooch sjukvårdspersonal har därför en central roll och bör hantera, vägleda, utbilda och göra patienten mer delaktig i behandlingen och därigenom främja en bättre medicinering följsamhet. Medicinering följsamhet är en stor utmaning för många patienter med kroniska tillstånd, äldre patient eller patient som är ordinerad för långvarig medicinering. Den snabba utvecklingen och användningen av mobiltelefoner inom vårdindustrin har en viktig roll att spela i detta område och har lett till utvecklingen av nya funktioner och applikationer som kan hjälpa både vårdgivare och patienter med att hantera och övervaka medicinsk intag. Denna utveckling och support av mobiltelefoner och applikationer har skapat och förbättrat interaktion mellan läkare och patient. Idag finns det inget enkelt sätt för sjukvårdspersonal att övervaka och hjälpa patienter med sina medicinintag. En lösning på detta problem är att utveckla en mobilapplikation som kommer att kommunicera med en smart pillbox via nära fältkommunikation (eng. Near Field Communication, NFC) för att övervaka, hantera och förbättra patientens medicinintag på ett enkelt och tillgängligt sätt. Med hjälp av NFC som kommunikationsteknik kommer data att överföras trådlöst från telefon till pillerdosa och vice versa. Denna lösning kommer att hjälpa vårdpersonal att skapa bättre behandlingsförhållanden och färre biverkningar för sina patienter. Dessa patienter kommer i sin tur att vara mer kunniga och motiverade att ta större ansvar i efterföljande läkares instruktioner och därigenom förbättra deras behandlingsprocess. Applikationen har testat och utvärderat under varje iteration av utvecklingsprocessen. Dessa tester har utförts genom att låta vårdpersonal testa applikationen och ge feedback på hur dem upplevar applikationen. Dessa tester hjälper till att skapa nya idéer, funktioner och funktioner som bör ingå i den slutliga applikationen, men också bidra till att förbättra användargränssnittet för att göra ansökan så användarvänlig som möjligt.